Study ties pre-hospitalization opioid use to elevated pneumonia risk | CDC: Risk of chronic opioid use rises after 5 days of therapy | Study: CSI scores lower using biopsychosocial rehab model
March 22, 2017
News for the pain professional
SIGN UP ⋅   FORWARD
Pain Research News
Study ties pre-hospitalization opioid use to elevated pneumonia risk
A study presented at the annual American Academy of Pain Medicine meeting found use of prescription opioids, such as fentanyl, codeine or morphine, in the 100 days prior to hospital admission was associated with a higher risk of hospital-acquired pneumonia, compared with no exposure to the drugs. The findings were based on 40,403 patients aged 18 to 70 years admitted to the Kaiser Permanente health system over four years.
Medscape (free registration) (3/20) 
LinkedIn Twitter Facebook Google+ Email
CDC: Risk of chronic opioid use rises after 5 days of therapy
CDC researchers reviewed data for nearly 1.3 million commercially insured adults without cancer and found that the probability of long-term opioid use sharply increased after five days of use, as well as after a second prescription and a 700 morphine-milligram-equivalent cumulative dose. The findings in the Morbidity and Mortality Weekly Report also showed that only 2.6% of patients continued opioid therapy for a year or more.
MedPage Today (free registration) (3/16) 
LinkedIn Twitter Facebook Google+ Email
Gain the Most In Demand Skills in Health Care
GW's School of Medicine Health Sciences connects you with leading authorities in policy and health care in Washington, D.C. With programs in clinical research, health care quality and regulatory affairs, you gain the most in demand skills. Learn More
ADVERTISEMENT
Advertisement
Treatment News
Study: CSI scores lower using biopsychosocial rehab model
The biopsychosocial model used by the Cleveland Clinic's interdisciplinary chronic pain rehabilitation program significantly improved patient pain scores measured by the Central Sensitization Inventory, researchers told the American Academy of Pain Medicine's annual meeting. Dr. Jordan Newmark of Stanford University said studies that show objective outcomes are important to gaining insurance reimbursement for pain rehab programs.
MedPage Today (free registration) (3/19) 
LinkedIn Twitter Facebook Google+ Email
Glucocorticoid injections offer limited help for back pain
More patients with discopathy-related lower back pain reported relief from one intradiscal glucocorticoid injection at one month, compared with those who did not get an injection, but at one year there was no difference between the groups in pain intensity or other health outcomes, researchers said. The study in the Annals of Internal Medicine found both groups had similar rates of adverse events.
Medscape (free registration) (3/21) 
LinkedIn Twitter Facebook Google+ Email
Other News
Policy & Trends
Study examines opioid exposure among US youths
More than 188,000 opioid exposure calls for youths younger than 20 were received by US poison control centers from January 2000 through December 2015, with exposures increasing by 86% from 2000 to 2009 before declining from 2009 to 2015, researchers reported in Pediatrics. The report also showed that 60% of exposures were among children younger than 5, while intentional opioid consumption was more likely among teens.
The Washington Post (tiered subscription model) (3/20),  CNBC (3/20) 
LinkedIn Twitter Facebook Google+ Email
States consider patient directives that prohibit opioids
Connecticut and Alaska are considering legislation to allow people to tell health care practitioners they do not want prescriptions for opioid medications. Massachusetts and Pennsylvania approved the creation of non-opioid voluntary directives last year.
STAT (tiered subscription model)/The Associated Press (3/19) 
LinkedIn Twitter Facebook Google+ Email
APS News
APS-CAT -- Conference on Analgesic Trials
APS-CAT is a full-day conference focused on optimizing the design and conduct of analgesic clinical trials. The goals of this conference are to gather world-renowned experts in clinical trials to convey and analyze current best practices, disseminate the latest scientific and regulatory developments in topics of interest to the analgesic research industry, discuss experimental methods that increase analgesic trial assay sensitivity, and engage audience members in dialogue with thought leaders in the field. Learn more.
LinkedIn Twitter Facebook Google+ Email
The Fundamentals of Translational Pain Medicine: Integrating Science into Clinical Care
Advances in the management of people in pain are linked to advances in basic science and its translation to clinical care. The Fundamentals Course will provide a foundation for students, trainees and early career pain scientists and clinicians with a translational focus for each topic presented. This course provides both pre-work and live interactive participation. Attendees will experience new levels of interdisciplinary integration in the science and treatment of patients with pain. Learn more.
LinkedIn Twitter Facebook Google+ Email
  
  
To different minds, the same world is a hell, and a heaven.
Ralph Waldo Emerson,
writer
LinkedIn Twitter Facebook Google+ Email
  
  
Learn more about APS:
Membership | Annual Meeting | Education
Funding Opportunities | About Us
Sign Up
SmartBrief offers 200+ newsletters
Advertise
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Wynn Hansen
P: 202.470.1149
Partner Relations Manager  -  Lauren Barr
Editor  -  Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2017 SmartBrief, Inc.®
Privacy policy |  Legal Information